16 research outputs found

    Additional file 1: Table S1. of Evaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure

    No full text
    Study population characteristics and demographic variables by T2D exposure. Provides a summary of study participant characteristics stratified by our primary exposure, type 2 diabetes. (DOCX 17 kb

    Actkins et al. PCOS Comorbidities Supplementary Material

    No full text
    This document contains supplementary material for "Comorbidity Differences by Race and Ethnicity Among Polycystic Ovary Syndrome Patients"

    African genetic ancestry interacts with body mass index to modify risk for uterine fibroids

    No full text
    <div><p>Race, specifically African ancestry, and obesity are important risk factors for uterine fibroids, and likely interact to provide the right conditions for fibroid growth. However, existing studies largely focus on the main-effects rather than their interaction. Here, we firstly provide evidence for interaction between categories of body mass index (BMI) and reported-race in relation to uterine fibroids. We then investigate whether the association between inferred local European ancestry and fibroid risk is modified by BMI in African American (AA) women in the Vanderbilt University Medical Center bio-repository (BioVU) (539 cases and 794 controls) and the Coronary Artery Risk Development in Young Adults study (CARDIA, 264 cases and 173 controls). We used multiple logistic regression to evaluate interactions between local European ancestry and BMI in relation to fibroid risk, then performed fixed effects meta-analysis. Statistical significance threshold for local-ancestry and BMI interactions was empirically estimated with 10,000 permutations (p-value = 1.18x10<sup>-4</sup>). Admixture mapping detected an association between European ancestry and fibroid risk which was modified by BMI (continuous-interaction p-value = 3.75x10<sup>-5</sup>) around <i>ADTRP</i> (chromosome 6p24); the strongest association was found in the obese category (ancestry odds ratio (AOR) = 0.51, p-value = 2.23x10<sup>-5</sup>). Evaluation of interaction between genotyped/imputed variants and BMI in this targeted region suggested race-specific interaction, present in AAs only; strongest evidence was found for insertion/deletion variant (6:11946435), again in the obese category (OR = 1.66, p-value = 1.72x10<sup>-6</sup>). We found nominal evidence for interaction between local ancestry and BMI at a previously reported region in chromosome 2q31-32, which includes <i>COL5A2</i>, and <i>TFPI</i>, an immediate downstream target of <i>ADTRP</i>. Interactions between BMI and SNPs (single nucleotide polymorphisms) found in this region in AA women were also detected in an independent European American population of 1,195 cases and 1,164 controls. Findings from our study provide an example of how modifiable and non-modifiable factors may interact to influence fibroid risk and suggest a biological role for BMI in fibroid etiology.</p></div

    Box plot of average European ancestry estimates in women from BioVU and CARDIA.

    No full text
    <p>Con = Controls; Ca = Cases; NW = normal-weight; OW = over-weight; Ob = obese; Average European ancestry by case control status in (a) BioVU, and (b) CARDIA; Average European ancestry by case-control status across BMI categories in (c) BioVU and (d) CARDIA.</p

    Regional association plots for SNP x BMI (continuous) interaction p-values for targeted region in chromosome 6 before and after meta-analysis with European American women.

    No full text
    <p>Plotted p-values are for BMI x SNP interaction term in the following scenarios: a) chromosome 6 region meta-analysis in BioVU AA and CARDIA AA; b) chromosome 6 region meta-analysis in BioVU AA and CARDIA AA + BIOVU EA.</p
    corecore